Aura Biosciences, Inc. Common Stock (AURA) is a publicly traded Healthcare sector company. As of July 5, 2026, AURA trades at $7.74 with a market cap of $800.60M and a P/E ratio of -4.40. AURA moved +14.86% today. Year to date, AURA is +40.98%; over the trailing twelve months it is +19.81%. Its 52-week range spans $4.35 to $11.22. Analyst consensus is strong buy with an average price target of $20.67. Rallies surfaces AURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AURA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $7.74 |
| Market Cap | $800.60M |
| P/E Ratio | -4.40 |
| EPS | $-1.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.22 |
| 52-Week Low | $4.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-106.19M |
| Gross Margin | 0.00% |
5 analysts cover AURA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.67.